AU6322686A - Pharmaceutical formulations with controlled release of the active substance - Google Patents

Pharmaceutical formulations with controlled release of the active substance

Info

Publication number
AU6322686A
AU6322686A AU63226/86A AU6322686A AU6322686A AU 6322686 A AU6322686 A AU 6322686A AU 63226/86 A AU63226/86 A AU 63226/86A AU 6322686 A AU6322686 A AU 6322686A AU 6322686 A AU6322686 A AU 6322686A
Authority
AU
Australia
Prior art keywords
active substance
controlled release
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU63226/86A
Other versions
AU598751B2 (en
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08503097A external-priority patent/GB2153643B/en
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU6322686A publication Critical patent/AU6322686A/en
Application granted granted Critical
Publication of AU598751B2 publication Critical patent/AU598751B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU63226/86A 1985-02-07 1986-09-29 Pharmaceutical formulations with controlled release of the active substance Expired AU598751B2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB08503097A GB2153643B (en) 1984-02-07 1985-02-07 Combined seed - fertiliser container
GB8524135 1985-10-01
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB8524653 1985-10-07
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB8531419 1985-12-20
GB8503097 1986-02-07
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions
GB8605037 1986-02-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU53020/90A Division AU626404B2 (en) 1985-10-01 1990-04-09 A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester

Publications (2)

Publication Number Publication Date
AU6322686A true AU6322686A (en) 1987-04-02
AU598751B2 AU598751B2 (en) 1990-07-05

Family

ID=27516573

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63226/86A Expired AU598751B2 (en) 1985-02-07 1986-09-29 Pharmaceutical formulations with controlled release of the active substance

Country Status (1)

Country Link
AU (1) AU598751B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
BE897821A (en) * 1982-09-27 1984-03-26 Sandoz Sa USE OF DIHYDROPHYRIDINE DERIVATIVES FOR THE TREATMENT OF ATHMA

Also Published As

Publication number Publication date
AU598751B2 (en) 1990-07-05

Similar Documents

Publication Publication Date Title
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
AU7754987A (en) Pharmaceutical formulations comprising microcapsules
EP0282951A3 (en) Controlled release preparations of active materials
AU4341789A (en) Pharmaceutical formulations
AU7756487A (en) Pharmaceutical formulations
AU3835885A (en) Controlled release liquid dosage formulations for pharmaceuticals
AU6119186A (en) Drug particles having constant release
NO862373D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES.
AU6119086A (en) Drug particles having constant release
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
AU3041789A (en) Pharmaceutical formulations with controlled drug release
SG103391G (en) Pharmaceutical formulations with controlled release of the active substance
AU2065588A (en) Pharmaceutical preparations for external use
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance
AU584266B2 (en) Azoniaspironortropanol esters, processes for the preparation thereof and pharmaceutical compositions containing them
IE850071L (en) Controlled release pharmaceutical formulations
AU1447388A (en) Cholesteryl-phosphoryl choline as pharmaceutically active substances
GB8503221D0 (en) Pharmaceutical formulations
HUT43925A (en) Insecticides comprising trihalogen-imidazole derivatives as active substance and process for preparing the active substances
IT8648494A0 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF THE ACTIVE SUBSTANCE
AU6642781A (en) Administration of medical active substances
LV5394A3 (en) Sediment for obtaining a medicament with controlled release of the active substance